# Main Line Fertility Clinic P.C. – FDA Inspection, Sep 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/main-line-fertility-clinic-pc/e293a359-6c7e-44d0-ae75-e66f44e6a468
Source feed: FDA_Inspections

> FDA inspection 1220397 of Main Line Fertility Clinic P.C., September 14, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220397
- Company Name: Main Line Fertility Clinic P.C.
- Inspection Date: 2023-09-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1085521 - 2019-04-08](https://www.keypedia.com/records/fda_inspections/main-line-fertility-clinic-pc/c4e90a29-349b-40f4-9e4e-33504c561748)
- FDA Inspection 989118 - 2016-10-19
- FDA Inspection 830799 - 2013-05-08
- FDA Inspection 734330 - 2011-06-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/main-line-fertility-clinic-pc/d5f7e4af-6fef-4172-88e1-3e2b6548d2cd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
